How big is the implantable cardioverter defibrillator market | Size, Share & Growth Forecast 2026

Code: MTA7070 Publication Date: Jul 2025

How big is the Implantable Cardioverter Defibrillator Market?

According to 6Wresearch internal database and industry insights, the Implantable Cardioverter Defibrillator (ICD) Market was valued at USD 7.5 Billion in 2025 and is projected to reach USD 11.2 Billion by 2032, growing at a CAGR of 5.8% during the forecast period of 2026–2032.

The market growth is driven by rising incidences of cardiac arrhythmias, advancements in device miniaturization, and increasing adoption of remote monitoring technologies.

Key Growth Drivers of the Implantable Cardioverter Defibrillator Market

  • Rising prevalence of cardiovascular diseases and sudden cardiac arrests
  • Technological advances in battery life and leadless ICDs
  • Growing awareness and screening for heart-related conditions
  • Government initiatives promoting cardiac healthcare
  • Expanding elderly population at higher risk of arrhythmias

Implantable Cardioverter Defibrillator Market Trends

The Implantable Cardioverter Defibrillator Market is experiencing increasing innovation in subcutaneous ICDs, which eliminate the need for transvenous leads, reducing infection risks. Real-time detection and alerting systems involving artificial intelligence-based monitoring systems are emerging. Bluetooth and remote communication integration is facilitating the continuous patient management. Moreover, biventricular ICDs and dual chambered ICDs are in investigation on how well they are working in improving treatments fatal heart failures.

Emerging Developments in the Implantable Cardioverter Defibrillator Market

The Implantable Cardioverter Defibrillator Market is advancing with developments like MRI-compatible ICDs and rechargeable implantable devices. The study is looking into biodegradable leads and compatibility in wearable defibrillation systems. Firms are also deploying data sharing (with an emphasis on cloud systems) and remote health platforms with the aim of guaranteeing timely treatment. Moreover, the partnership with telehealth firms is gaining, with the idea to better access in underprivileged and rural areas.

Major Companies in the Implantable Cardioverter Defibrillator Market

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • LivaNova PLC
  • Micro Port Scientific Corporation
  • Koninklijke Philips N.V.
  • Zoll Medical Corporation
  • Integer Holdings Corporation
  • SCHILLER AG

How big is the implantable cardioverter defibrillator market : FAQs

It was valued at USD 7.5 Billion in 2024 and is projected to reach USD 11.2 Billion by 2031.
The market is expected to grow at a CAGR of 5.8% from 2025 to 2031.
The market is driven by growing cardiac disease burden, technological innovation, and increased global awareness.
Transvenous ICDs, subcutaneous ICDs, dual-chamber, and biventricular ICDs.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All